SIRPA/Sirpα elevated levels are associated with tumor progression, as genetically engineered SIRPA−/− mice were demonstrated to have developed smaller subcutaneous MC38 tumors and exhibited prolonged survival, while rechallenged tumors were completely rejected. Here, SIRPA is linked to neoplasm.